Presentation

Ultrasound, Radiation and Chemicals: What Constitutes a Disruptive Technology in Sympathetic Neuromodulation?

Presenter: Peter Fitzgerald

October 27, 2013

REGISTER for free or LOG IN to view this content

Ultrasound, Radiation and Chemicals: What Constitutes a Disruptive Technology in Sympathetic Neuromodulation?

Renovascular

Presentation

TCT 2013

Up Next

Presentation

Which High-Risk AS Patients Should be Treated with TAVR and Which are Better Suited for Surgical AVR

Presenter: Neil Moat

October 27, 2013

More slides +

Presentation

Setting up a Thriving Clinical Research Program: The Basics and More

Presenter: David Cox

October 27, 2013

Presentation

Inspiron Stent and 2-year FIH Follow-up

Presenter: Pedro Lemos

October 27, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.